Dr. Luca Palliotti has joined Dreamgenics as a medical advisor in neurology

November 24, 2025

We are pleased to welcome Dr. Luca Palliotti, a neurologist with extensive international training and clinical experience in the field of neuromuscular diseases, as Dreamgenics’ new medical advisor.

Dr. Palliotti earned his medical degree from the University of Perugia (Italy), completing part of his training at theMedical University of Warsaw (Warsaw, Poland) and at the Universidade do Grande Rio (Rio de Janeiro, Brazil). He subsequently specialized in neurology at the Hospital Clínico San Carlos in Madrid. He is currently a member of the Neurophysiology and Neuromuscular Pathology Unit at QuirónSalud Madrid University Hospital and Ruber Juan Bravo University Hospital, where he focuses his clinical work on the diagnosis and treatment of neuromuscular diseases, with a special interest in genetic disorders. In addition to his clinical work, Dr. Palliotti conducts clinical electromyography studies and serves as a professor at the European University, contributing to the training of future healthcare professionals.

Dr. Palliotti highlights“the fundamental role that genetics plays today in the management of neuromuscular diseases. The emergence of targeted therapies and gene therapies capable of altering the natural course of these conditions has completely transformed our clinical landscape. Therefore, having an accurate—and specifically genetic—diagnosis is no longer merely desirable, but absolutely essential to offering each patient the best possible therapeutic option.” He also highlights the collaboration with Dreamgenics “as a unique opportunity to continue advancing the application of precision genetics to the diagnosis and management of neuromuscular diseases.”

For his part, Carlos Martínez, CEO of Dreamgenics, states: “Dr. Palliotti is joining our team as a medical advisor in the field of neurology, specializing in disorders of the peripheral nervous system, alongside Dr. Ayuga, a specialist in the central nervous system and dementia. This addition is yet another demonstration of our commitment to offering neurologists and our patients the most comprehensive service possible, both in terms of genetic testing and clinical counseling.”

Share